Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)

NCT01069770 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma
Metastasis

Interventions

DRUG: Sunitinib

Sponsor

Korean Urological Oncology Society

Collaborators

[object Object]